Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.41 USD
-0.07 (-4.73%)
Updated Jun 6, 2024 03:59 PM ET
After-Market: $1.41 0.00 (0.00%) 7:04 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.52 | 0.00% |
Earnings Summary
For their last quarter, Iterum Therapeutics (ITRM) reported earnings of -$0.46 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 19.30%. Look out for ITRM's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.52 per share, reflecting a year-over-year increase of 45.26%.
Earnings History
Price & Consensus
Zacks News for ITRM
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services